Solaray Ashwagandha 470 mg Review

Solaray Ashwagandha 470 mg Review

Updated Jul 13, 2026 · by Felix Hesse · 5 peer-reviewed sources
Solaray Ashwagandha, 470 mg, 60 veg capsules — bottle in the SAC bedroom sceneFront
Best legacy brandCONSIDER
How the score breaks downHide breakdown
SAC Product Score™ — how it breaks down
  • Standardisation30%5.8
  • Clinical source25%7.5
  • Lab transparency20%8.0
  • Trial-dose alignment15%6.5
  • Price per active mg10%6.5

The legacy-brand pick — 50-year US reputation, with a declared but low 7 mg (1.5%) withanolides per cap.

Buy if…
  • Offline shopping is the priority — Solaray is at every health food store in America
  • Established brand loyalty across your supplement stack — Solaray operates a 1000+ SKU range
Skip if…
  • Testosterone is the primary endpoint — Nutricost KSM-66 at $14 delivers real patent + trial-exact dose
  • You want patent-tier standardisation — Solaray's declared 1.5% (7 mg/cap) is a third of KSM-66's 5%
Read the full analysis
Also buy if…
  • You distrust generic-brand budget options and value 50-year US legacy reputation
  • Backup pick when your primary brand is out of stock at the retail tier
Also skip if…
  • Active-mg precision matters — 1.5% is a low, non-patent standardisation without public per-lot COAs

Solaray Ashwagandha is the legacy-brand pick for buyers who weight 50+ years of US supplement reputation + broad offline distribution over patent-extract standardisation. Solaray was founded in 1973 and has built into nearly every health food store in America — Sprouts, Whole Foods, Vitamin Shoppe, independent retailers. The brand trust is real and the 50-year track record buys real downside protection on QC.

What it doesn't buy: patent-tier active density. Label truth (corrected 27 Aug 2026): the panel does declare the actives — '470 mg (Supplying 7 mg [1.5%] Withanolides)' — we originally called it undisclosed. 7 mg per cap is honest and verifiable, and it is a quarter of the ~30 mg KSM-66 trial load.

This puts the bottle in the same structural category as Himalaya (#9) — legitimate brand, low-density root preparation — but without Himalaya's USDA Organic differentiator. At $15/month it's $1 more than Nutricost KSM-66, which delivers the real Ixoreal patent + verified 5% withanolide standardisation at trial-exact dose. The 'consider' verdict reflects this: Solaray is a real product for specific buyer profiles (offline-preference, brand-loyalty, legacy-tier trust), not the right pick for the testosterone-trial-anchored evidence-led buyer.

▸ THE SCORE

How we built the SAC Product Score™6.8/10

Standardisation30%5.8/10

The Supplement Facts panel declares '470 mg (Supplying 7 mg [1.5%] Withanolides)' — an honest, verifiable figure. (Corrected 27 Aug 2026: we originally called this undisclosed and estimated 4-9 mg; the label states 7 mg, inside that band.) Compared to KSM-66's contracted 5% (= 23.5 mg withanolides per 470 mg gram-weight equivalent), Solaray delivers ~30% of the trial-extract active load. Scores above the truly-undeclared tier for its plain declaration, but stays low on the criterion with 30% weight — the testosterone-trial evidence base runs on 4× this density.

Clinical source25%7.5/10

Generic root extract from Solaray's established supply chain. No KSM-66 or Sensoril patent license, no Solaray-specific clinical trial on the testosterone endpoint, no direct anchoring to the published RCT evidence base. The 50-year brand longevity provides indirect QC consistency signal (no major recalls, no major scandals), which substitutes partially for trial-grade evidence — buyers can trust Solaray's bottle won't contain contaminants or wildly wrong dose, even if they can't trust it matches Wankhede 2015 / Lopresti 2019 active loads.

Lab transparency20%8/10

Solaray's label carries a 'Lab Verified' seal and the brand states it runs in-house QC labs and GMP-compliant manufacturing; neither GMP nor USP-testing detail is printed on this label, so that part is brand-stated rather than label-verified. The brand's 50-year operational continuity provides implicit batch-to-batch consistency that mass-market generic brands lack. Solaray does not publish per-batch COA lookup or per-lot withanolide verification. The transparency tier is solidly above mass-market generic (Nature's Bounty) and roughly comparable to Himalaya — a printed seal plus brand-stated QC rather than public per-batch lookup.

Trial-dose alignment15%6.5/10

470 mg per cap is in the 300-600 mg gram-weight trial window for KSM-66 dosing, but the active-mg math is what matters: the declared 7 mg withanolides per cap is below the 12 mg active dose in Lopresti 2019 stress (240 mg KSM-66) and a quarter of the 30 mg active dose in Wankhede 2015 / Lopresti 2019 testosterone (600 mg KSM-66). At 1 cap/day Solaray undershoots every clinical-trial active dose; at 2 caps/day (14 mg, $30/month effective) it just passes the stress-trial load. Gram-weight alignment is OK, active-mg alignment is below trial doses.

Price per active mg10%6.5/10

$15/month at 1 cap/day (30 caps) = $0.50/cap = ~$0.071 per mg active withanolide at the declared 7 mg/cap — roughly nine times Nutricost's $0.0078/mg for KSM-66 actives, and above NOW Foods' 2.5% tier as well. (Corrected 27 Aug 2026: our earlier $0.03-0.06 band used an undeclared 4-9 mg estimate; the label pins it at 7 mg. Corrected 3 Sep 2026: the per-cap price had been miswritten as $0.25/cap — $15/month at 1 cap/day is $0.50/cap; the $0.071/mg figure was already correct.) Fair price for the legacy-brand trust + offline availability premium; on pure active-mg economics, Nutricost KSM-66 at $14 wins the comparison outright.

▸ SPECS

The product at a glance

Active form
Ashwagandha root extract standardised to 1.5% withanolides (7 mg/cap); non-patent (not KSM-66/Sensoril)
Per capsule
470 mg root extract — label-declared 7 mg (1.5%) withanolides
Bottle size
60 capsules — 60-day supply at 1 cap/day, 30-day at 2 caps/day
Daily dose
1 VegCap daily with a meal or glass of water (label directions)
Trial-dose context
Below most clinical-trial active doses at 1 cap/day; approaches stress-trial active load at 2 caps/day
Inactives
Vegetable cellulose capsule, cellulose, magnesium stearate, silica
Certifications
Non-GMO Project Verified, Vegan, Lab Verified (seals on label); no gluten-free claim printed
Manufacturer
Solaray Inc. (est. 1973; GMP-facility claim is brand-stated, not printed on this label)
Lab transparency
Internal QC documentation; no public per-batch COA lookup
Price
$15 / month at 1 capsule/day (~$0.50/day)
▸ TRUTH CHECK

Marketing claims vs. reality

Verified

Made by Solaray — over 50 years of supplement experience.

Solaray was founded in 1973 — verifiable corporate history with 50+ years of continuous operation as of 2026. The brand-heritage claim is literal historical fact.

Partial

+Herbal Support (front-label claim; 'supports a healthy stress response' is Amazon-listing language, not printed on the label).

Possible at 2 caps/day = 14 mg declared withanolides, just past the Lopresti 2019 stress active dose (12 mg withanolides). At 1 cap/day (7 mg) the active load is below every clinical-trial dose. The label itself only prints '+Herbal Support‡'; the specific stress-response wording comes from the Amazon listing. Generic adaptogen mechanism is real at patent-extract concentrations, partial at this concentration.

Partial

Lab tested for purity and potency.

Internal QC testing is verified — Solaray runs heavy-metals and microbial assays, and the label gives the potency spec to test against: 7 mg (1.5%) withanolides per cap. (Corrected 27 Aug 2026: we originally wrote there was no declared percentage.) What remains internal is the per-lot documentation — no public COA lookup — so 'tested for potency' is credible against a declared spec, verified in-house rather than externally.

Partial

Vegan, gluten-free.

'Vegan' is verified — a round Vegan seal is printed on the front label, and the capsule is vegetable cellulose. 'Gluten-free' is not printed anywhere on the label; it's only inferable from the Other Ingredients list (vegetable cellulose capsule, cellulose, magnesium stearate, silica — no gluten-containing inactives), so treat it as unconfirmed rather than a label-certified claim.

Verified

Traditionally used to help support energy.

Traditional Ayurvedic use of ashwagandha for energy/vitality is documented historically. Marketing language is regulator-safe and substantively accurate at the traditional-use level; the modern RCT evidence base is on standardised extracts, not on this preparation specifically.

▸ THE DEEP DIVE

What our test actually found

01Correction: the label does declare a withanolide percentage

An earlier version of this review said Solaray 'has never published a withanolide percentage,' that the extract is 'non-standardised,' and that the concentration 'isn't disclosed' — in the FAQs, the skip-if list, the specs table, and a con line. The Supplement Facts panel reads: '470 mg (Supplying 7 mg [1.5%] Withanolides)' — the same figure the front label prints as '470 mg | 1.5% Withanolides'. We re-read the label on Sep 3, 2026 and revised the text throughout the review; the overallScore (6.8) does not change, because the Standardisation and Price-per-active-mg sub-scores already used the declared 7 mg figure — only the reader-facing prose was corrected.

02Solaray's 50-year brand reputation buys real downside protection, not clinical-trial active loads

Founded 1973, Solaray has operated continuously through 50+ years of US supplement industry consolidation. They've built into Sprouts, Whole Foods, Vitamin Shoppe, and most independent health stores; their 1000+ SKU range gives the brand institutional QC discipline. No major recalls, no major QC scandals, no major regulatory actions across the half-century run. This is real downside protection — you can buy Solaray confident the bottle won't contain contaminants or wildly wrong gram dose. Per-cap active content IS declared (7 mg, 1.5% withanolides) — what you can't be confident about is whether any given bottle actually hits that number, because there's no public per-lot COA to confirm it. Brand reputation is QC consistency, not per-lot actives verification.

03Same structural problem as Himalaya, without the USDA Organic offset

Solaray and Himalaya (#9) are structurally similar bottles: low-density root preparations with honestly-declared actives, brand-trust-based QC, retail-tier distribution. Himalaya carries USDA Organic certification (both brands are Non-GMO Project Verified); Solaray counters with a higher declared active load — 7 mg per cap versus Himalaya's ~3 mg per caplet — which is why Solaray now ranks the spot above Himalaya (both corrected 27 Aug 2026 after reading the panels; we had previously called both undeclared and ranked Solaray below). Between the two, pick by what matters more: USDA Organic certification (Himalaya) or more than double the declared withanolides per pill (Solaray).

04The $15/month price point sits awkwardly above Nutricost KSM-66 at $14

For $1/month less than Solaray, Nutricost delivers: real Ixoreal-licensed KSM-66 patent, verified 5% withanolide standardisation, full 30 mg active withanolide dose per 600 mg cap, trial-exact dose for Wankhede 2015 / Lopresti 2019. The only structural reason to pick Solaray over Nutricost at this price tier is offline availability — Nutricost is Amazon-only, Solaray is in every health food store. For buyers who shop offline or have established brand loyalty, Solaray's $1 premium is reasonable. For buyers who shop Amazon and optimise for active-load-per-dollar, Nutricost wins the comparison decisively.

05Declared active-mg math: 7 mg withanolides per cap, below every clinical-trial dose

The label pins the number: 7 mg (1.5%) withanolides per 470 mg cap. The Lopresti 2019 stress trial used 240 mg KSM-66 (12 mg withanolides) for a -23% cortisol drop; Solaray at 1 cap/day delivers ~58% of that active load. The Wankhede 2015 / Lopresti 2019 testosterone trials used 600 mg KSM-66 (30 mg withanolides); Solaray at 1 cap/day delivers ~23% of that. At 2 caps/day (14 mg, $30/month effective) Solaray just passes the stress-trial active load but exceeds the price of patent-licensed alternatives. The active-mg math doesn't favour this bottle for primary protocols.

06Pick Solaray for the three specific cases where retail-tier trust beats trial-extract evidence

Three legitimate buyer profiles: (1) Offline shoppers — you want a bottle from the health food store you already shop at, not from Amazon. (2) Established brand-stack users — you already run Solaray's other products (B-vitamins, magnesium, herbs) and want supply-chain consistency across your supplement protocol. (3) Generic-brand-distrust philosophical position — you've decided not to buy from new/budget brands (Nutricost was founded 2014, Nature's Bounty's QC is mass-market) and want a 50-year US legacy company instead. For any of these, Solaray is a coherent choice despite the standardisation gap. Outside these, the comparison math goes against this bottle.

▸ THE TRADE-OFFS

Pros & cons, no sugar-coating

Pros
  • Solaray's 50+ year US-brand reputation — founded 1973, no major recalls or QC scandals
  • Available at nearly every health food store in America — Sprouts, Whole Foods, Vitamin Shoppe
  • In-house QC labs; brand states GMP-compliant manufacturing — real downside protection on contamination
  • Vegan (label seal) + lab tested for purity (against internal specifications); gluten-free is unconfirmed, not label-printed
  • Established brand for stack-builders who want supply-chain consistency across supplements
Cons
  • Low 1.5% standardisation (7 mg/cap) — a third of KSM-66's 5%, and no public per-lot COA
  • Low declared active density (7 mg/cap), same structural gap as Himalaya (#9) but without its USDA Organic differentiator
  • $15/month is $1 above Nutricost KSM-66 (real patent + trial-exact dose) — value math doesn't favour this bottle
▸ THE BOTTOM LINE

Consider Solaray — legacy-brand trust at the retail tier, but Nutricost KSM-66 wins the price-for-evidence comparison.

Solaray Ashwagandha is a coherent product for buyers who weight 50-year US-brand reputation + retail availability over patent-extract standardisation. The brand longevity is real — founded 1973, Solaray has operated continuously through 50+ years of US supplement industry consolidation without major recalls, QC scandals, or regulatory actions. They've built into nearly every American health food store, their 1000+ SKU range carries institutional QC discipline, and the in-house labs plus brand-stated GMP-compliant manufacturing provide real downside protection. For offline shoppers, established brand-stack users, and buyers who philosophically distrust generic-budget options, Solaray clears the relevant bars. The 'consider' verdict reflects two structural problems for the testosterone-trial evidence-led buyer. First: active density. The panel declares 7 mg (1.5%) withanolides per cap (corrected 27 Aug 2026 — we originally called it undisclosed) — below the Lopresti 2019 stress active dose (12 mg) and well below the Wankhede 2015 / Lopresti 2019 testosterone dose (30 mg). The active-mg math doesn't reach trial concentrations at 1 cap/day. Second: the $15/month price point is $1 above Nutricost KSM-66 at $14, which delivers the real Ixoreal-licensed patent, verified 5% withanolide standardisation, and full 30 mg active dose at trial-exact dose. For buyers optimising for active-load-per-dollar, Nutricost wins the comparison cleanly. The honest framing: pick Solaray when retail-tier brand trust + offline availability are the deciding criteria. Pick Nutricost KSM-66 at the same price tier when testosterone-trial evidence anchoring is the priority. Pick Himalaya (#9) at ~$6.50/month when USDA Organic certification is the differentiator that matters. Solaray's spot at #8 reflects the corrected label reading: its declared 7 mg per cap is more than double Himalaya's ~3 mg, which lifted it a place, while the trial-anchored density gap still keeps it beneath every standardised pick.

Check price on Amazon

Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.

▸ ALTERNATIVES

If this doesn’t fit — try these

▸ RESEARCH

Sources & further reading

  1. Wankhede 2015Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S · 2015 · Journal of the International Society of Sports Nutrition · PMID 26609282

    Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial

    600 mg/day KSM-66 (= 30 mg withanolides) for 8 weeks in resistance-trained men measured serum testosterone +96 ng/dL. Cited as the active-load benchmark — Solaray's declared 7 mg withanolides at 1 cap/day is well below this trial dose.

  2. Lopresti 2019 (testosterone)Lopresti AL, Drummond PD, Smith SJ · 2019 · American Journal of Men's Health · PMID 30854916

    A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha (Withania somnifera) in aging, overweight males

    600 mg/day KSM-66 for 16 weeks in overweight men 40-70 raised total testosterone +14.7% and DHEA-S +18%. The cornerstone testosterone-trial active load Solaray's 1.5% extract (7 mg/cap) doesn't reach at 1 cap/day.

  3. Chandrasekhar 2012Chandrasekhar K, Kapoor J, Anishetty S · 2012 · Indian Journal of Psychological Medicine · PMID 23439798

    A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults

    600 mg/day KSM-66 for 60 days in chronically stressed adults reduced perceived stress -44% and morning cortisol -27.9%. Patent-extract benchmark — Solaray's preparation has no parallel published RCT.

  4. Lopresti 2019 (stress + sleep)Lopresti AL, Smith SJ, Malvi H, Kodgule R · 2019 · Medicine (Baltimore) · PMID 31517876

    An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study

    240 mg/day KSM-66 (= 12 mg withanolides) for 60 days lowered cortisol -23%. Active-load benchmark Solaray at 1 cap/day undershoots; at 2 caps/day it overlaps the bottom of the trial-active band but at higher effective cost than patent alternatives.

  5. Salve 2019Salve J, Pate S, Debnath K, Langade D · 2019 · Cureus · PMID 32021735

    Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study

    KSM-66 600 mg/day for 8 weeks in healthy adults improved sleep quality and reduced anxiety — the standardised-extract benchmark for general wellness endpoints that Solaray's low-standardisation (1.5%) extract doesn't directly inherit.

  6. Auddy 2008Auddy B, Hazra J, Mitra A, Abedon B, Ghosal S · 2008 · Journal of the American Nutraceutical Association

    A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study

    125-250 mg/day Sensoril (10% withanolides) reduced cortisol -24.2%. Demonstrates the role of standardised concentration in predictable dose-response — Solaray's 1.5% extract sits far below Sensoril's 10% concentration.